Dogwood Therapeutics Statistics
Share Statistics
Dogwood Therapeutics has 1.91M
shares outstanding. The number of shares has increased by null%
in one year.
| Shares Outstanding | 1.91M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 4,824 |
| FTD / Avg. Volume | 0.26% |
Short Selling Information
The latest short interest is 93.2K, so 4.88% of the outstanding
shares have been sold short.
| Short Interest | 93.2K |
| Short % of Shares Out | 4.88% |
| Short % of Float | 4.99% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.21 and the forward
PE ratio is null.
Dogwood Therapeutics's PEG ratio is
-0.01.
| PE Ratio | -0.21 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0.04 |
| P/FCF Ratio | -0.29 |
| PEG Ratio | -0.01 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Dogwood Therapeutics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.21,
with a Debt / Equity ratio of 0.24.
| Current Ratio | 5.21 |
| Quick Ratio | 5.21 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | -1.27 |
| Debt / FCF | -1.77 |
| Interest Coverage | -132.63 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,029,143.67 |
| Employee Count | 12 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -503 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -48.86% in the
last 52 weeks. The beta is 2.01, so Dogwood Therapeutics's
price volatility has been higher than the market average.
| Beta | 2.01 |
| 52-Week Price Change | -48.86% |
| 50-Day Moving Average | 5.38 |
| 200-Day Moving Average | 4.94 |
| Relative Strength Index (RSI) | 52.49 |
| Average Volume (20 Days) | 1,861,886 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -12.23M |
| Net Income | -12.35M |
| EBITDA | -12.25M |
| EBIT | -12.26M |
| Earnings Per Share (EPS) | -9.42 |
Full Income StatementBalance Sheet
The company has 14.85M in cash and 15.59M in
debt, giving a net cash position of -737.71K.
| Cash & Cash Equivalents | 14.85M |
| Total Debt | 15.59M |
| Net Cash | -737.71K |
| Retained Earnings | -73.82M |
| Total Assets | 94.31M |
| Working Capital | 13.37M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -8.79M
and capital expenditures 0, giving a free cash flow of -8.79M.
| Operating Cash Flow | -8.79M |
| Capital Expenditures | n/a |
| Free Cash Flow | -8.79M |
| FCF Per Share | -8.55 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
